Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06925295 · ClinicalTrials.gov registry record · Phase 2
Using Xe MRI to Guide Radiation Therapy for Lung Cancer
A Phase 2 study of Imaging Techniques, sponsored by Sean Fain.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06925295 is a Phase 2 study of Imaging Techniques that is actively recruiting participants, run by Sean Fain. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06925295, a Phase 2 study of Imaging Techniques, is actively recruiting participants, sponsored by Sean Fain.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to explore using MRI scans with xenon to better image lung function, how lung function changes after radiation therapy, and to guide radiation therapy away from parts of the lung that have good function. This project is foundational to performing additional studies to establish if novel MRI imaging can serve as a guidance tool for lung cancer radiation treatment.
Conditions Studied
Interventions
- OTHER Quality of Life Questionnaire
- DRUG Xenon MRI
- DIAGNOSTIC_TEST Pulmonary Function Testing
- OTHER Medical Research Council Dyspnea score
- OTHER St. George's Respiratory Questionnaire
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-08-30 |
| Est. Completion | 2027-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06925295
The ClinicalTrials.gov registry entry for NCT06925295 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sean Fain, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Imaging Techniques appearing as the primary indexed condition, and to 5 interventions - of which Quality of Life Questionnaire is the first listed.
NCT06925295 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT06925295 about?
NCT06925295 is a clinical study titled "Using Xe MRI to Guide Radiation Therapy for Lung Cancer". The purpose of this research study is to explore using MRI scans with xenon to better image lung function, how lung function changes after radiation therapy, and to guide radiation therapy away from parts of the lung that have good function. This project is foundational to performing additional stud...
What is the current status of trial NCT06925295?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2025-08-30. Estimated completion is 2027-01.
What conditions does trial NCT06925295 study?
This clinical trial studies the following conditions: Imaging Techniques.
What interventions are being tested in trial NCT06925295?
The interventions under investigation include: Quality of Life Questionnaire (OTHER), Xenon MRI (DRUG), Pulmonary Function Testing (DIAGNOSTIC_TEST), Medical Research Council Dyspnea score (OTHER), St. George's Respiratory Questionnaire (OTHER).
Who is sponsoring clinical trial NCT06925295?
This trial is sponsored by Sean Fain, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06925295 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.